Thank you to our study coordinators Martha Almond, Noelle Knight, and Carole Robinette for their time and help with the clinical trial at UNC for molnupiravir, an oral pill, developed by Merck/Ridgeback, which was endorsed to treat COVID in the UK.
Molnupiravir, a new oral drug for COVID treatment has been endorsed to treat COVID in the UK
